Long-term Efficacy of Erenumab in Patients with Chronic Migraine Who Failed Prior Prophylactic Treatment

被引：0
|
作者：
Ashina, M. [1 ]
Tepper, S. J. [2 ]
Brandes, J. [3 ]
Boudreau, G. [4 ]
Dolezil, D. [5 ]
Klatt, J. [6 ]
Zhang, F. [7 ]
Cheng, S. [7 ]
Mikol, D. D. [7 ]
机构：
[1] Rigshosp Glostrup, Glostrup, Hovedstaden, Denmark
[2] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03766 USA
[3] Nashville Neurosci Grp, Nashville, TN USA
[4] Ctr Traitement Neurol, Montreal, PQ, Canada
[5] Prague Headache Ctr, Prague, Jihocesky Kraj, Czech Republic
[6] Novartis Pharma AG, Basel, Basel Stadt, Switzerland
[7] Amgen Inc, Thousand Oaks, CA USA
来源：
HEADACHE | 2018年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PF106LB
引用
收藏
页码：1296 / 1297
页数：2
相关论文
共 50 条
  • [21] The efficacy of repetitive prophylactic treatment in long-term relief from migraine
    Kouroumalos, N.
    Korakaki, D.
    Labiris, C.
    Kalamafkianaki, K.
    Karatzaferis, L.
    Kalafatis, E.
    Georgakakis, G.
    Nikolakaki, E.
    JOURNAL OF NEUROLOGY, 2007, 254 : 176 - 176
  • [22] Long-Term Efficacy of Fremanezumab in Patients with Episodic Migraine and Chronic Migraine Who Failed at Least One Prior Migraine Preventive Medication: Results from 6-and 12-Month Studies
    Dougherty, Carrie
    Ning, Xiaoping
    Cohen, Joshua M.
    Yang, Ronghua
    Campos, Verena Ramirez
    Seminerio, Michael
    Silberstein, Stephen D.
    ANNALS OF NEUROLOGY, 2020, 88 : S154 - S155
  • [23] Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura
    Ashina, Messoud
    Dodick, David
    Goadsby, Peter J.
    Kudrow, David
    Reuter, Uwe
    Tepper, Stewart J.
    Cheng, Sunfa
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [24] Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura
    Ashina, Messoud
    Dodick, David
    Goadsby, Peter
    Kudrow, David
    Reuter, Uwe
    Tepper, Stewart
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert
    Mikol, Daniel
    NEUROLOGY, 2018, 90
  • [25] OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort
    di Cola, Francesca Schiano
    Pari, Elisa
    Caratozzolo, Salvatore
    Mancinelli, Chiara
    Liberini, Paolo
    Rao, Renata
    Padovani, Alessandro
    NEUROLOGICAL SCIENCES, 2018, 39 : S159 - S160
  • [26] OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort
    Francesca Schiano di Cola
    Elisa Pari
    Salvatore Caratozzolo
    Chiara Mancinelli
    Paolo Liberini
    Renata Rao
    Alessandro Padovani
    Neurological Sciences, 2018, 39 : 159 - 160
  • [27] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (04): : 653 - 661
  • [28] Efficacy of Long-Term Fremanezumab Treatment in Patients with Chronic or Episodic Migraine and Prior Inadequate Response to Multiple Migraine Preventive Medication Classes
    Naegel, Steffen
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Ning, Xiaoping
    Carr, Karen
    Kudrow, David
    ANNALS OF NEUROLOGY, 2021, 90 : S132 - S133
  • [29] Assessment of the Long-Term Safety and Efficancy of Erenumab During Open-Label Treatment of Patients With Chronic Migraine
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (15)
  • [30] INDIRECT COMPARISON OF THE EFFICACY OF FREMANEZUMAB VERSUS ERENUMAB IN EPISODIC MIGRAINE PATIENTS WHO HAD FAILED 2-4 PRIOR MIGRAINE PREVENTIVE TREATMENTS
    Patterson-Lomba, O.
    Thompson, S.
    Gandhi, S. K.
    Yang, R.
    Cohen, J.
    Mu, F.
    Young, J.
    VALUE IN HEALTH, 2019, 22 : S737 - S737
12345